TY - JOUR
T1 - Study of drug resistance in pulmonary tuberculosis cases in south coastal Karnataka
AU - Rao, Parashuram
AU - Chawla, Kiran
AU - Shenoy, Vishnu Prasad
AU - Mukhopadhyay, Chiranjay
AU - Brahmavar, Vishwanath
AU - Kamath, Asha
AU - Mohapatra, Aswini Kumar
PY - 2015/9/1
Y1 - 2015/9/1
N2 - The present cross-sectional study was conducted for the first time from the Udupi district of coastal Karnataka to know the prevalence of drug resistance and comparative analysis of MDR and non-MDR cases of pulmonary tuberculosis. Details of 862 smear positive cases of pulmonary tuberculosis with age ≥15 years from 12 designated microscopy centres of the Udupi district were studied. Initially 2 sputum samples trailed by one follow-up sample were collected from each patient and processed for culture and drug sensitivity on the Lowenstein-Jensen medium. A total resistance of 33.4% was observed that includes the mono-resistance of 22.5%, multidrug resistance (MDR) of 6.3% and extensive drug resistance (XDR) of 0.3%. Significant odds ratio (OR) was observed in category 2 cases (OR 3.9) for the development of MDR tuberculosis. A significant statistical association was observed using Fisher's exact test while comparing mortality rate (19.3% vs. 1.8%), treatment failure (8.8% vs. 3.8%) and cure rate (68.4% vs. 85.4%) between MDR and non-MDR cases (p < 0.001). Category 2 patients are important risk factors for the development of MDR in pulmonary tuberculosis. Due to high mortality and low cure rate in MDR cases it is imperative to know the drug sensitivity report before institution of anti-tubercular treatment.
AB - The present cross-sectional study was conducted for the first time from the Udupi district of coastal Karnataka to know the prevalence of drug resistance and comparative analysis of MDR and non-MDR cases of pulmonary tuberculosis. Details of 862 smear positive cases of pulmonary tuberculosis with age ≥15 years from 12 designated microscopy centres of the Udupi district were studied. Initially 2 sputum samples trailed by one follow-up sample were collected from each patient and processed for culture and drug sensitivity on the Lowenstein-Jensen medium. A total resistance of 33.4% was observed that includes the mono-resistance of 22.5%, multidrug resistance (MDR) of 6.3% and extensive drug resistance (XDR) of 0.3%. Significant odds ratio (OR) was observed in category 2 cases (OR 3.9) for the development of MDR tuberculosis. A significant statistical association was observed using Fisher's exact test while comparing mortality rate (19.3% vs. 1.8%), treatment failure (8.8% vs. 3.8%) and cure rate (68.4% vs. 85.4%) between MDR and non-MDR cases (p < 0.001). Category 2 patients are important risk factors for the development of MDR in pulmonary tuberculosis. Due to high mortality and low cure rate in MDR cases it is imperative to know the drug sensitivity report before institution of anti-tubercular treatment.
UR - http://www.scopus.com/inward/record.url?scp=84937978413&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937978413&partnerID=8YFLogxK
U2 - 10.1016/j.jegh.2015.01.002
DO - 10.1016/j.jegh.2015.01.002
M3 - Article
C2 - 25689297
AN - SCOPUS:84937978413
SN - 2210-6006
VL - 5
SP - 275
EP - 281
JO - Journal of Epidemiology and Global Health
JF - Journal of Epidemiology and Global Health
IS - 3
ER -